Supporting Investor Presentations
Introduction
Our client was an early clinical-stage company developing novel small-molecule therapies for the treatment of a rare respiratory disorder. As their pipeline development was underway, continued engagement with business development partners and investors was needed.
Additionally, the client wanted to begin preparing the market for their upcoming suite of therapies. This therapeutic area had deeply entrenched treatment practices and a long-standing standard of care.
The Challenge
While the client had compelling proof-of-concept data and a novel therapeutic strategy, they struggled to communicate their science and value story effectively. Many of their materials were complex, data-heavy, ineffective in design, and contained quality control issues. The client wanted support in clearly communicating key information about their portfolio and technology to resonate with investors and support funding efforts.
Our Solution
- Strategic Alignment: Engaged with the Client team to understand their corporate and clinical strategies and align on the crucial communication points essential for inclusion in the slide decks.
- Investors needed to understand that the Client’s compounds were well-characterized and could meet the unmet needs that were not appropriately addressed by the standard of care.
- It is important to underscore the flexibility and optionality of their suite of therapies.
- Investor Deck Development: Our team crafted outlines and developed slide decks aligned to the strategy.
- Designed to effectively convey the unmet need, the innovative therapeutic strategy, key predictive data, and developmental milestones.
- Recreated data graphs and developed custom visuals aligned with the narrative.
Value Delivered
We created concise, consistent decks that effectively communicated the programs’ value, playing a key role in securing Series C investment. Investors highly praised the well-structured presentations for their clarity and ability to facilitate a swift understanding of the programs.
